Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium Channel Blockade in Primary Aldosteronism
NCT04179019Phase 2Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Sep 2020
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amlodipine in primary aldosteronism (PA), sponsored by Brigham and Women's Hospital. Started Sep 2020; status: completed.
02
Drugs
amlodipine
03
Conditions
primary aldosteronism (PA)
Beyond the preview
Go deeper on NCT04179019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04179019.